NAMS Launches Free Mobile Menopause App


A new mobile app is now available to help women and their providers make decisions about managing symptoms related to menopause.

[[{"type":"media","view_mode":"media_crop","fid":"28616","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_4415872411336","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2919","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"line-height: 1.538em; float: right;","title":"Screen shot of MenoPro app logo.","typeof":"foaf:Image"}}]]The North American Menopause Society (NAMS) announced today during their 25th Annual Meeting in Washington, DC, that a menopause mobile app is now available. What's unique about this app is that it's the first-ever menopause mobile app designed for use by both clinicians and patients, and it can be used to help manage menopausal symptoms and, importantly, to assess risk factors.

Called MenoPro, the app offers access to NAMS resources (for both clinicians and patients) and an internal cardiovascular disease risk score calculator. The MenoPro app also offers clinicians the ability to email a summary of the decision-making process and informational pages/handouts that are relevant to each patient. Some of its other unique features include the following:
- Options for managing hot flashes and/or night sweats.
- Options for evaluating genitourinary syndromes, including vaginal dryness or dyspareunia.
- Links to good information about lifestyle modifications, treatment options, formulations and doses, and contraindications to therapy.

"This new app represents a major step forward for both clinicians and patients looking to make more informed health care decisions," stated JoAnn Manson, MD, NAMS scientific program chair and a past president of the society, in a prepared statement. She also said that she expects this new app to revolutionize the management of menopausal symptoms by using the most recent science to help clinicians identify which patients are candidates for pharmacologic treatment and to personalize their care.

Margery Gass, MD, executive director of NAMS, added her thoughts. "One of the most difficult and controversial health care decisions most women face during midlife is whether or not to use prescription medications for menopausal symptom management," she said. "Given the expanded array of treatment options and contradictory information available, many women feel overwhelmed. But this new app is designed to streamline the decision-making process and encourages patients to communicate and work together with their clinicians to identify a personalized treatment path."

And did we mention that it's advertising free? If you have an iPhone or iPad, head to the App Store to check it out. (For those of you on android devices, a version will be coming soon.)

Related Videos
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit:
Hot flashes poorly impact sleep quality | Image Credit:
What's new in endometrium care? | Image Credit:
How to manage bone health in midlife women | Image Credit: -
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting | Image Credit: Yale School of Medicine
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit:
How fezolinetant changes management of hot flashes | Image Credit:
Fezolinetant effective against vasomotor symptoms | Image Credit:
Gloria Richard-Davis MD, MBA, NCMP, FACOG
Related Content
© 2024 MJH Life Sciences

All rights reserved.